{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:38:46Z","timestamp":1780353526859,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To identify and comprehensively evaluate studies capturing the experience of individuals affected by an inherited optic neuropathy (ION), focusing on patient-reported outcome measures (PROMs) and qualitative studies where the health status and quality of life (QoL) of these individuals have been explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Systematic review of five databases using a search strategy combining four concepts: (1) ION; (2) QoL and health status; (3) PROMs; and (4) qualitative research. Studies assessing the impact of ION on any QoL domain using a PROM or qualitative methodology were included and appraised, using criteria based on the COSMIN checklist (for PROM studies) and the CASP checklist (for qualitative studies).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 1326 unique articles identified, six studies were included. Five PROMs were identified: Visual Function Index (VF-14); Hospital Anxiety and Depression Scale (HADS); a novel graphical online assessment tool (NGOAT) for reporting emotional response to vision loss; a new PROM informed by the DSM-V Criteria for Major Depressive Disorder; and an interpersonal and career \u2018impact rating\u2019 PROM. The psychometric performance of included PROMs were poorly described. Qualitative studies found that vision loss resulted in psychosocial losses including loss of social and communication skills and loss of independence and freedom. Factors that modified the response to vision loss were also identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The current PROMs used by individuals with ION have poor content coverage, primarily measuring activity limitation and emotional well-being, and insufficient reporting of psychometric performance. There is a need to develop a PROM for individuals ION to report their experiences of living with their condition. <\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-021-05534-0","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T08:03:31Z","timestamp":1642061011000},"page":"2045-2055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Capturing the experiences of patients with inherited optic neuropathies: a systematic review of patient-reported outcome measures (PROMs) and qualitative studies"],"prefix":"10.1007","volume":"260","author":[{"given":"Benson S.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Galus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerija","family":"Tadi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Pesudovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasanee","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"5534_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","volume":"18","author":"NJ Newman","year":"2004","unstructured":"Newman NJ, Biousse V (2004) Hereditary optic neuropathies. Eye (Lond) 18:1144\u20131160. https:\/\/doi.org\/10.1038\/sj.eye.6701591","journal-title":"Eye (Lond)"},{"key":"5534_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF (2011) Mitochondrial optic neuropathies - Disease mechanisms and therapeutic strategies. Prog Retin Eye Res 30:81\u2013114. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002","journal-title":"Prog Retin Eye Res"},{"key":"5534_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1167\/iovs.07-1132","volume":"49","author":"KG Csaky","year":"2008","unstructured":"Csaky KG, Richman EA, Ferris FL 3rd (2008) Report from the NEI\/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci 49:479\u2013489. https:\/\/doi.org\/10.1167\/iovs.07-1132","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5534_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/jamaophthalmol.2013.7971","volume":"132","author":"BL Lam","year":"2014","unstructured":"Lam BL, Feuer WJ, Schiffman JC, Porciatti V, Vandenbroucke R, Rosa PR, Gregori G, Guy J (2014) Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy\u202f: Preparation for gene therapy clinical trial. JAMA Ophthalmol 132:428\u2013436. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.7971","journal-title":"JAMA Ophthalmol"},{"key":"5534_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/PROM.S162802","volume":"10","author":"T Braithwaite","year":"2019","unstructured":"Braithwaite T, Calvert M, Gray A, Pesudovs K, Denniston AK (2019) The use of patient-reported outcome research in modern ophthalmology: Impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas 10:9\u201324. https:\/\/doi.org\/10.2147\/PROM.S162802","journal-title":"Patient Relat Outcome Meas"},{"key":"5534_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.survophthal.2016.12.011","volume":"62","author":"M Prem Senthil","year":"2017","unstructured":"Prem Senthil M, Khadka J, Pesudovs K (2017) Assessment of patient-reported outcomes in retinal diseases: a systematic review. Surv Ophthalmol 62:546\u2013582. https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.011","journal-title":"Surv Ophthalmol"},{"key":"5534_CR7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/bjophthalmol-2013-303350","volume":"97","author":"V Tadic","year":"2013","unstructured":"Tadic V, Hogan A, Sobti N, Knowles RL, Rahi JS (2013) Patient-reported outcome measures (PROMs) in paediatric ophthalmology: A systematic review. Br J Ophthalmol 97:1369\u20131381. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-303350","journal-title":"Br J Ophthalmol"},{"key":"5534_CR8","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2147\/PPA.S255264","volume":"14","author":"S Fernandes","year":"2020","unstructured":"Fernandes S, Fond G, Zendjidjian XY, Baumstarck K, Lancon C, Berna F, Schurhoff F, Aouizerate B, Henry C, Etain B, Samalin L, Leboyer M, Llorca PM, Coldefy M, Auquier P, Boyer L, French PG (2020) Measuring the patient experience of mental health care: A systematic and critical review of patient-reported experience measures. Patient Prefer Adherence 14:2147\u20132161. https:\/\/doi.org\/10.2147\/PPA.S255264","journal-title":"Patient Prefer Adherence"},{"key":"5534_CR9","unstructured":"Critical Appraisal Skills Programme (CASP) (2018) CASP qualitative checklist. https:\/\/casp-uk.b-cdn.net\/wp-content\/uploads\/2018\/03\/CASP-Qualitative-Checklist-2018_fillable_form.pdf. Accessed 2 December 2020"},{"key":"5534_CR10","doi-asserted-by":"publisher","first-page":"e413","DOI":"10.1111\/aos.12077","volume":"91","author":"M Bailie","year":"2013","unstructured":"Bailie M, Votruba M, Griffiths PG, Chinnery PF, Yu-Wai-Man P (2013) Visual and psychological morbidity among patients with autosomal dominant optic atrophy. Acta Ophthalmol 91:e413-414. https:\/\/doi.org\/10.1111\/aos.12077","journal-title":"Acta Ophthalmol"},{"key":"5534_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/WNO.0000000000000644","volume":"39","author":"S Cui","year":"2019","unstructured":"Cui S, Jiang H, Peng J, Wang J, Zhang X (2019) Evaluation of Vision-Related Quality of Life in Chinese Patients With Leber Hereditary Optic Neuropathy and the G11778A Mutation. J Neuroophthalmol 39:56\u201359. https:\/\/doi.org\/10.1097\/WNO.0000000000000644","journal-title":"J Neuroophthalmol"},{"key":"5534_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0264619615616260","volume":"34","author":"J Ferguson","year":"2016","unstructured":"Ferguson J, de Abreu G (2016) What is the lived experience for people with Leber hereditary optic neuropathy? Br J Vis Impair 34:109\u2013120. https:\/\/doi.org\/10.1177\/0264619615616260","journal-title":"Br J Vis Impair"},{"key":"5534_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.psym.2016.07.002","volume":"58","author":"J Gale","year":"2017","unstructured":"Gale J, Khoshnevis M, Frousiakis SE, Karanjia R, Poincenot L, Sadun AA, Baron DA (2017) An international study of emotional response to bilateral vision loss using a novel graphical online assessment tool. Psychosomatics 58:38\u201345. https:\/\/doi.org\/10.1016\/j.psym.2016.07.002","journal-title":"Psychosomatics"},{"key":"5534_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/OPTH.S113414","volume":"11","author":"GA Garcia","year":"2017","unstructured":"Garcia GA, Khoshnevis M, Gale J, Frousiakis SE, Hwang TJ, Poincenot L, Karanjia R, Baron D, Sadun AA (2017) Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clin Ophthalmol 11:417\u2013427. https:\/\/doi.org\/10.2147\/OPTH.S113414","journal-title":"Clin Ophthalmol"},{"key":"5534_CR15","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1167\/iovs.08-3166","volume":"50","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, Klopstock T, Griffiths PG, Hudson G, Chinnery PF, Yu-Wai-Man P (2009) Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 50:3112\u20133115. https:\/\/doi.org\/10.1167\/iovs.08-3166","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5534_CR16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington","edition":"5"},{"key":"5534_CR17","unstructured":"World Health Organization (WHO) (2001) International classification of functioning, disability and health: ICF. http:\/\/whqlibdoc.who.int\/publications\/2001\/9241545429.pdf. Accessed 2 December 2020"},{"key":"5534_CR18","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s11136-012-0110-1","volume":"21","author":"EK Fenwick","year":"2012","unstructured":"Fenwick EK, Pesudovs K, Khadka J, Dirani M, Rees G, Wong TY, Lamoureux EL (2012) The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res 21:1771\u20131782. https:\/\/doi.org\/10.1007\/s11136-012-0110-1","journal-title":"Qual Life Res"},{"key":"5534_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/IJG.0b013e318287ac11","volume":"24","author":"J Khadka","year":"2015","unstructured":"Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K (2015) Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. J Glaucoma 24:12\u201319. https:\/\/doi.org\/10.1097\/IJG.0b013e318287ac11","journal-title":"J Glaucoma"},{"key":"5534_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archopht.1994.01090170074026","volume":"112","author":"EP Steinberg","year":"1994","unstructured":"Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD, Legro MW, Diener-West M, Bass EB, Damiano AM et al (1994) The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112:630\u2013638. https:\/\/doi.org\/10.1001\/archopht.1994.01090170074026","journal-title":"Arch Ophthalmol"},{"key":"5534_CR21","unstructured":"National Institute for Health and Care Excellence (NICE) Commissioning Support Programme (2020) Clinical commissioning policy: Idebenone for treating people over 12 years of age with Leber\u2019s hereditary optic neuropathy. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/07\/Idebenone-for-treating-people-over-12-years-of-age-with-LHO-Neuropathy.pdf. Accessed 2 December 2020"},{"key":"5534_CR22","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1167\/iovs.04-0208","volume":"45","author":"JA Stelmack","year":"2004","unstructured":"Stelmack JA, Szlyk JP, Stelmack TR, Demers-Turco P, Williams RT, Moran D, Massof RW (2004) Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci 45:3919\u20133928. https:\/\/doi.org\/10.1167\/iovs.04-0208","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5534_CR23","first-page":"927","volume":"43","author":"LM Weih","year":"2002","unstructured":"Weih LM, Hassell JB, Keeffe J (2002) Assessment of the impact of vision impairment. Invest Ophthalmol Vis Sci 43:927\u2013935","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5534_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/s0277-9536(98)00411-0","volume":"48","author":"GL Albrecht","year":"1999","unstructured":"Albrecht GL, Devlieger PJ (1999) The disability paradox: High quality of life against all odds. Soc Sci Med 48:977\u2013988. https:\/\/doi.org\/10.1016\/s0277-9536(98)00411-0","journal-title":"Soc Sci Med"},{"key":"5534_CR25","doi-asserted-by":"publisher","first-page":"e1002966","DOI":"10.1371\/journal.pmed.1002966","volume":"16","author":"CA Rees","year":"2019","unstructured":"Rees CA, Pica N, Monuteaux MC, Bourgeois FT (2019) Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis. PLoS Med 16:e1002966. https:\/\/doi.org\/10.1371\/journal.pmed.1002966","journal-title":"PLoS Med"},{"key":"5534_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/eye.2017.49","volume":"31","author":"RK Jones","year":"2017","unstructured":"Jones RK, Jefferis JM (2017) Is qualitative research under-represented in ophthalmology journals? Eye (Lond) 31:1117\u20131119. https:\/\/doi.org\/10.1038\/eye.2017.49","journal-title":"Eye (Lond)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05534-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05534-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T10:06:00Z","timestamp":1651485960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05534-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5534"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05534-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BSC is recipient of the Cambridge-Rutherford Memorial Scholarship awarded by the Royal Society Te Ap\u0101rangi \u2013 Rutherford Foundation and the Cambridge Commonwealth, European & International Trust, and also the Aotearoa New Zealand Fellows Research Entry Scholarship awarded by the Royal Australasian College of Physicians (RACP). PYWM is supported by an Advanced Fellowship Award (NIHR301696) from the UK National Institute of Health Research (NIHR) and a Clinician Scientist Fellowship Award (G1002570) from the UK Medical Research Council (MRC). PYWM also receives funding from Fight for Sight (UK), the Isaac Newton Trust (UK), Moorfields Eye Charity (GR001376), the Addenbrooke\u2019s Charitable Trust, the National Eye Research Centre (UK), the International Foundation for Optic Nerve Disease (IFOND), the NIHR as part of the Rare Diseases Translational Research Collaboration, the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014), and the NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}